{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:58Z","timestamp":1787678458747,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110222","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:55:59Z","timestamp":1783439759000},"page":"110222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of novel pyrazolines and isoxazolines as antileishmanial agents via a potential antifolate mechanism: synthesis, biological evaluation, and in silico studies"],"prefix":"10.1016","volume":"180","author":[{"given":"Menna","family":"Desouky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna S.","family":"Hany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Elaraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan A.","family":"Bekhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.","family":"Hany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pcl.2015.08.002","article-title":"Infectious Diseases of Poverty in Children: A Tale of Two Worlds","volume":"63","author":"Hansen","year":"2016","journal-title":"Pediatr. Clin. N. Am."},{"issue":"10151","key":"10.1016\/j.bioorg.2026.110222_bb0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/emph\/eoaa032","article-title":"Leishmaniasis: A spectrum of diseases shaped by evolutionary pressures across diverse life cycle","volume":"2020","author":"Antonia","year":"2020","journal-title":"Evolut., Med., Public Health"},{"key":"10.1016\/j.bioorg.2026.110222_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.10.022","article-title":"Leishmania treatment and prevention: Natural and synthesized drugs","volume":"160","author":"Bekhit","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bse0510063","article-title":"Folate metabolic pathways in Leishmania","volume":"51","author":"Vickers","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115333","article-title":"Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: Design, synthesis and computational studies","volume":"253","author":"Hassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0035","series-title":"Leishmaniasis","author":"Organization, W.H","year":"2025"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110222_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13090812","article-title":"Advances in Leishmania Vaccines: Current Development and Future Prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110222_bb0045","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110222_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12050706","article-title":"Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host","volume":"12","author":"Singh","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.bioorg.2026.110222_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1051\/parasite\/2025035","article-title":"Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy","volume":"32","author":"Al Samra","year":"2025","journal-title":"Parasite"},{"key":"10.1016\/j.bioorg.2026.110222_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115609","article-title":"The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis","volume":"258","author":"Pal","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110222_bb0065","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1074\/jbc.M110.209593","article-title":"Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major","volume":"286","author":"Ong","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110222_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-6851(01)00213-4","article-title":"Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy","volume":"113","author":"Cunningham","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bioorg.2026.110222_bb0075","article-title":"An Overview on the Therapeutics of Neglected Infectious Diseases-Leishmaniasis and Chagas Diseases","volume":"9","author":"Chanda","year":"2021","journal-title":"Front. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110222_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24599","article-title":"Global distribution of treatment resistance gene markers for leishmaniasis","volume":"36","author":"Salari","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110222_bb0085","first-page":"393","article-title":"Biochemical characterization of the bifunctional enzyme dihydrofolate reductase-thymidylate synthase from Leishmania (Viannia) and its evaluation as a drug target","volume":"33","author":"Osorio","year":"2013","journal-title":"Biomedica"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110222_bb0090","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.3390\/molecules28227526","article-title":"In Silico and In Vitro Search for Dual Inhibitors of the Trypanosoma brucei and Leishmania major Pteridine Reductase 1 and Dihydrofolate Reductase","volume":"28","author":"Possart","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/jm901059x","article-title":"Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases","volume":"53","author":"Tulloch","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110222_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000956","article-title":"2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach","volume":"5","author":"Mercer","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2026.110222_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1493906","article-title":"Synthesis, enzyme inhibition, and docking studies of new schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents","author":"Al-Wahaibi","year":"2024","journal-title":"Front. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110222_bb0110","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.bmcl.2016.07.010","article-title":"Design, synthesis and antimalarial evaluation of novel thiazole derivatives","volume":"26","author":"Bueno","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110222_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1475-2875-10-283","article-title":"In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum","volume":"10","author":"Andriantsoanirina","year":"2011","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10715762.2020.1859107","article-title":"Proportional coexistence of okanin chalcone glycoside and okanin flavanone glycoside in Bidens pilosa leaves and theoretical investigation on the antioxidant properties of their aglycones","volume":"55","author":"Kabanda","year":"2021","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110222_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101250","article-title":"Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry","volume":"15","author":"Rajendran","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110222_bb0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/14756366.2014.949255","article-title":"Synthesis, characterization and biological evaluation of novel 4\u2032-fluoro-2\u2032-hydroxy-chalcone derivatives as antioxidant, anti-inflammatory and analgesic agents","volume":"30","author":"Abdellatif","year":"2015","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0135","first-page":"27(20)","article-title":"Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives","author":"Dhaliwal","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13104-020-05132-z","article-title":"Ultrastructural alterations in Plasmodium falciparum induced by chalcone derivatives","volume":"13","author":"Sinha","year":"2020","journal-title":"BMC Res. Notes"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110222_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20428","article-title":"Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis","volume":"9","author":"Nematollahi","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0150","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1080\/14756366.2022.2117316","article-title":"New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations","volume":"37","author":"Bekhit","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0155","first-page":"06","article-title":"Recent Synthetic Methodologies for Chalcone Synthesis (2013-2018)","author":"Farooq","year":"2019","journal-title":"Curr. Organocatal."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110222_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1248\/yakushi.20-00214","article-title":"Asymmetric Hetero-Michael Additions to \u03b1,\u03b2-Unsaturated Carboxylic Acids by Multifunctional Boronic Acid Catalysts","volume":"141","author":"Hayama","year":"2021","journal-title":"Yakugaku Zasshi"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110222_bb0165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent Modifiers: A Chemical Perspective on the Reactivity of \u03b1,\u03b2-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions","volume":"60","author":"Jackson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0170","article-title":"Synthesis and Anti-Inflammatory Activity of Pyrazolines","volume":"7","author":"Ramesh","year":"2010","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fvets.2020.00527","article-title":"Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum","volume":"7","author":"Souza","year":"2020","journal-title":"Front. Vet. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110222_bb0180","first-page":"1053","article-title":"Antileishmanial assessment of isoxazole derivatives against L. donovani. RSC","volume":"11","author":"Mukhopadhyay","year":"2020","journal-title":"Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110222_bb0185","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.3390\/molecules17066179","article-title":"Synthesis of chalcones with anticancer activities","volume":"17","author":"Syam","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110222_bb0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: Design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110222_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","article-title":"FRED and HYBRID docking performance on standardized datasets","volume":"26","author":"McGann","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110222_bb0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1107\/S2053230X22002795","article-title":"Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+\/NADPH and the substrate folic acid","volume":"78","author":"Dello Iacono","year":"2022","journal-title":"Acta Crystallogr. Sect. F"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmb.2005.06.076","article-title":"Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor Design","volume":"352","author":"Sch\u00fcttelkopf","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110222_bb0210","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1107\/S0907444903013131","article-title":"Structure of pteridine reductase (PTR1) from Leishmania tarentolae","volume":"59","author":"Zhao","year":"2003","journal-title":"Acta Crystallogr. Sect. D"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ph18010006","article-title":"Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors","volume":"18","author":"Arthur","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110222_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00249-023-01677-6","article-title":"Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design","volume":"52","author":"Panecka-Hofman","year":"2023","journal-title":"Eur. Biophys. J."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110222_bb0225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/ci050357s","article-title":"Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation","volume":"46","author":"Cheeseright","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110222_bb0230","series-title":"Cresset\u00ae: Litlington, Cambridgeshire, UK","author":"Flare\u2122","year":"2025"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110222_bb0235","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","article-title":"Analysis of Protein Folding Simulation with Moving Root Mean Square Deviation","volume":"63","author":"Maruyama","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0240","first-page":"72","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"Aust. J. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110222_bb0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00436-002-0695-3","article-title":"A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species","volume":"88","author":"Teixeira","year":"2002","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bioorg.2026.110222_bb0250","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.12.051","article-title":"Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies","volume":"92","author":"Mendoza-Mart\u00ednez","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2019.06.051","article-title":"Synthesis, in\u00a0vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents","volume":"179","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0260","first-page":"1","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"43","key":"10.1016\/j.bioorg.2026.110222_bb0265","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0270","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2026.110222_bb0275","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-Dynamics with Coupling to An External Bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0280","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10659-010-9250-0","article-title":"On (Andersen\u2013)Parrinello\u2013Rahman Molecular Dynamics, the Related Metadynamics, and the Use of\u00a0the\u00a0Cauchy\u2013Born Rule","volume":"100","author":"Podio-Guidugli","year":"2010","journal-title":"J. Elast."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110222_bb0285","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110222_bb0290","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110222_bb0295","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"issue":"20","key":"10.1016\/j.bioorg.2026.110222_bb0300","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110222_bb0305","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0310","series-title":"MDAnalysis: a Python package for the rapid analysis of molecular dynamics simulations","author":"Gowers","year":"2016"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110222_bb0315","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110222_bb0320","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110222_bb0325","first-page":"123","article-title":"StreaMD: the toolkit for high-throughput molecular dynamics simulations","volume":"16","author":"Ivanova","year":"2024","journal-title":"Aust. J. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110222_bb0330","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1517\/13543776.2011.587804","article-title":"Antifolate agents: a patent review (2006 - 2010)","volume":"21","author":"Wright","year":"2011","journal-title":"Expert Opin Ther Pat"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110222_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006969","article-title":"Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening","volume":"12","author":"Turcano","year":"2018","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:34:45Z","timestamp":1787675685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0045206826007583"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110222","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel pyrazolines and isoxazolines as antileishmanial agents via a potential antifolate mechanism: synthesis, biological evaluation, and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110222"}}